AXIS - The Reimbursement Experts

Gold Sponsor

AXIS Reimbursement is a specialist market access and HTA advisory firm supporting pharmaceutical and biotechnology companies to successfully bring innovative therapies to market across Europe and the UK.

Founded in Ireland in 2012, AXIS has built a strong reputation for delivering high-quality strategic support across the product lifecycle. The company works closely with clients to differentiate and position new medicines, enabling successful reimbursement and patient access in complex healthcare systems.

AXIS offers a full suite of services including early economic modelling, HTA strategy, global and EU value dossiers, medical writing, data analytics, and pricing & reimbursement advisory. With deep expertise across key HTA bodies including NCPE, NICE and SMC, AXIS ensures that value propositions are aligned to payer requirements and optimised for successful outcomes.

To date, AXIS has completed over 120 HTA submissions across Ireland and the UK, achieving a success rate of over 97%. The company partners with leading global pharmaceutical and biotech organisations.

As part of its international growth strategy, AXIS is expanding its presence in the US, working with biotech and pharma companies at Phase II/III to support early-stage market access strategy and enable successful entry into EU and UK markets.

AXIS Reimbursement – Your EU & UK Market Access Partner.